Latest New Zealand News

Reckon Limited posted a modest revenue increase to $54.1 million for FY2024, yet net profit declined by 25.7%, reflecting margin pressures despite operational gains. The company also announced a strategic acquisition aimed at bolstering future growth.

CSL Limited has announced a USD 1.30 per share dividend for the half-year ending December 2024, marking a steady return for investors despite the payout being fully unfranked.

Vulcan Steel Limited has announced a fully franked ordinary dividend of NZD 0.02588235 per share for the six months ending December 2024, payable on March 27, 2025. The dividend includes a supplementary component for Australian shareholders.

Vulcan Steel’s 1H FY25 results reveal a steep decline in profitability amid tough economic conditions, yet the company signals cautious optimism for a market rebound in 2025.

Vulcan Steel Limited reported a 12.6% revenue decline and a 64.8% drop in net profit for the first half of FY25 amid challenging market conditions. Despite this, the company achieved a 10% return on capital employed and is positioning itself for growth as economic recovery signs emerge.

Vulcan Steel Limited reported a challenging first half of FY25 with significant declines in revenue, EBITDA, and net profit, yet maintained a solid 10% return on capital employed and declared a cautious interim dividend.

Foresta Group Holdings has signed a non-binding term sheet with Genesis Energy to supply torrefied wood pellets for Huntly Power Station, marking a pivotal step toward reducing New Zealand’s coal dependency by 2028.

Pro-Pac Packaging has updated its quarterly cash flow report, highlighting a net cash outflow from operations and outlining plans to improve margins and secure longer-term funding.

Australian Foundation Investment Company Limited has updated its interim dividend announcement, detailing foreign currency exchange rates and pricing for its Dividend Reinvestment and Substitution Share Plans. The fully franked dividend of AUD 0.12 per share is set for payment on February 25, 2025.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.